ONY Biotech

A privately held neonatal pharmaceutical company, ONY Biotech is a leader in the creation of critically important products for the treatment of premature infants. We innovate with a singular purpose: to improve outcomes for premature babies and their families. 

ONY Biotech’s primary commercial product, Infasurf® (calfactant), helps prevent and treat respiratory distress syndrome in newborns. As a USA-born biotech, we take pride in the work we do, delivering treatments that serve families here in the United States and around the world.